Followers | 4053 |
Posts | 151195 |
Boards Moderated | 4 |
Alias Born | 08/05/2009 |
Monday, August 23, 2021 3:38:38 PM
Recent VVOS News
- Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement • GlobeNewswire Inc. • 04/09/2024 11:30:00 AM
- Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 03/28/2024 08:05:00 PM
- Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call • GlobeNewswire Inc. • 03/28/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 01:55:42 PM
- Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Proceeds • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 10:42:51 PM
- Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities • GlobeNewswire Inc. • 02/06/2024 12:30:00 PM
- Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA • GlobeNewswire Inc. • 01/08/2024 12:30:00 PM
- Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway” • GlobeNewswire Inc. • 12/11/2023 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/04/2023 05:15:05 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 12/01/2023 09:12:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 09:05:34 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/30/2023 09:03:04 PM
- Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea • GlobeNewswire Inc. • 11/29/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/22/2023 09:46:39 PM
- Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 11/14/2023 09:05:00 PM
- Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call • GlobeNewswire Inc. • 11/09/2023 09:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/03/2023 09:00:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 09:10:35 PM
- Vivos Therapeutics Closes $4 Million Private Placement • GlobeNewswire Inc. • 11/02/2023 09:00:01 PM
- Vivos Therapeutics Announces Pricing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 10/31/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:33 PM
- Vivos Therapeutics Announces Reverse Stock Split • GlobeNewswire Inc. • 10/26/2023 11:30:00 AM
- Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare • GlobeNewswire Inc. • 10/24/2023 11:30:00 AM
- Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine • GlobeNewswire Inc. • 10/11/2023 11:30:00 AM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM